These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 22831484)

  • 41. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene doping.
    Haisma HJ; de Hon O
    Int J Sports Med; 2006 Apr; 27(4):257-66. PubMed ID: 16572366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time for change: a roadmap to guide the implementation of the World Anti-Doping Code 2015.
    Dvorak J; Baume N; Botré F; Broséus J; Budgett R; Frey WO; Geyer H; Harcourt PR; Ho D; Howman D; Isola V; Lundby C; Marclay F; Peytavin A; Pipe A; Pitsiladis YP; Reichel C; Robinson N; Rodchenkov G; Saugy M; Sayegh S; Segura J; Thevis M; Vernec A; Viret M; Vouillamoz M; Zorzoli M
    Br J Sports Med; 2014 May; 48(10):801-6. PubMed ID: 24764550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An integrative 'omics' solution to the detection of recombinant human erythropoietin and blood doping.
    Pitsiladis YP; Durussel J; Rabin O
    Br J Sports Med; 2014 May; 48(10):856-61. PubMed ID: 24627340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hormone abuse in sports: the antidoping perspective.
    Barroso O; Mazzoni I; Rabin O
    Asian J Androl; 2008 May; 10(3):391-402. PubMed ID: 18385901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 2011 lAAF World Championships in Daegu: blood tests for all athletes in the framework of the Athlete Biological Passport.
    Robinson N; Dollé G; Garnier PY; Saugy M
    Bioanalysis; 2012 Jul; 4(13):1633-43. PubMed ID: 22831479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analytical challenges in sports drug testing.
    Thevis M; Krug O; Geyer H; Walpurgis K; Baume N; Thomas A
    Anal Bioanal Chem; 2018 Mar; 410(9):2275-2281. PubMed ID: 29445832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
    Geyer H; Schänzer W; Thevis M
    Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Challenges and threats to implementing the fight against doping in sport.
    Dvorak J; Saugy M; Pitsiladis YP
    Br J Sports Med; 2014 May; 48(10):807-9. PubMed ID: 24764551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A synopsis of the adverse analytical and atypical findings between 2005 and 2011 from the Doping Control Laboratory of Athens in Greece.
    Kioukia-Fougia N; Fragkaki A; Kiousi P; Leontiou IP; Dimopoulou H; Tsivou M; Lyris E; Georgakopoulos C
    J Anal Toxicol; 2014; 38(1):16-23. PubMed ID: 24194481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thirteen years of the fight against doping in figures.
    Aguilar M; Muñoz-Guerra J; Plata MDM; Del Coso J
    Drug Test Anal; 2017 Jun; 9(6):866-869. PubMed ID: 28105782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Running ahead of doping: analytical advances and challenges faced by modern laboratories ahead of Rio 2016.
    Aquino Neto FR; Sarderla VF; Mirotti L; Pizzatti L
    Bioanalysis; 2016 Sep; 8(17):1753-6. PubMed ID: 27491844
    [No Abstract]   [Full Text] [Related]  

  • 53. Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.
    Zorzoli M; Pipe A; Garnier PY; Vouillamoz M; Dvorak J
    Br J Sports Med; 2014 May; 48(10):862-6. PubMed ID: 24648438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of the emergence of designer drugs upon sports doping testing.
    Teale P; Scarth J; Hudson S
    Bioanalysis; 2012 Jan; 4(1):71-88. PubMed ID: 22191595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Doping droops.
    Chaturvedi A; Chaturvedi H; Kalra J; Kalra S
    Indian J Physiol Pharmacol; 2007; 51(2):118-30. PubMed ID: 18175655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. History of mass spectrometry at the Olympic Games.
    Hemmersbach P
    J Mass Spectrom; 2008 Jul; 43(7):839-53. PubMed ID: 18570181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Walpurgis K; Geyer H; Schänzer W
    Drug Test Anal; 2016 Jan; 8(1):7-29. PubMed ID: 26767774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The analytical chemistry of drug monitoring in athletes.
    Bowers LD
    Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():485-507. PubMed ID: 20636072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mass spectrometry and illicit drug testing: analytical challenges of the anti-doping laboratories.
    Botrè F
    Expert Rev Proteomics; 2008 Aug; 5(4):535-9. PubMed ID: 18761462
    [No Abstract]   [Full Text] [Related]  

  • 60. Medicine and science in the fight against doping in sport.
    Catlin DH; Fitch KD; Ljungqvist A
    J Intern Med; 2008 Aug; 264(2):99-114. PubMed ID: 18702750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.